TABLE 1.

Demographics and clinical characteristic of patients

Patient ID	Recipient HLA-DR	Donor HLA-DR	Time post-transplant (y)	Age	Gender	Clinical outcome (at time of testing)
PPG26	4, 11	15, 15	1.6	46	Male	Some element of BOS
PPG96	17, 14	9, 15	2	55	Female	Presumed antibody−mediated acute rejection treated with pulse steroids at 1 y
PPG99	4, 7	1, 15	3.1	68	Male	Signs of increased obstruction including a decreased ratio and significant change in FEV1
PPG95	4, 4	14, 15	1.7	67	Male	Stable with very good pulmonary graft function, FEV1 103%
PPG97	4, 11	14, 15	2.7	69	Male	Stable graft function, FEV1 107%
PPG98	17, 7	17, 15	4.2	63	Male	Stable with very good pulmonary graft function
L86	1, 11	1, 15	14	69	Male	Stable graft function at the time of testing

BOS, bronchiolitis obliterans syndrome.